Clinical Trials Browser

Phase 4 × Hepatitis B, Chronic × peginterferon alfa-2a × Clear all

NCT03253250 2017-09-08

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic